Loading...

Phillips 66 Partners LP

PSXPNYSE
Energy
Oil & Gas Midstream
$42.01
$0.78(1.89%)
U.S. Market is Open • 13:18

Phillips 66 Partners LP Fundamental Analysis

Phillips 66 Partners LP (PSXP) shows moderate financial fundamentals with a PE ratio of 12.45, profit margin of 67.80%, and ROE of -518.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Operating Margin75.65%
PEG Ratio-2.16

Areas of Concern

ROE-518.00%
Current Ratio0.34
We analyze PSXP's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -40341.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-40341.0/100

We analyze PSXP's fundamental strength across five key dimensions:

Efficiency Score

Excellent

PSXP demonstrates superior asset utilization.

ROA > 10%
10.94%

Valuation Score

Excellent

PSXP trades at attractive valuation levels.

PE < 25
12.45
PEG Ratio < 2
-2.16

Growth Score

Moderate

PSXP shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PSXP shows balanced financial health with some risks.

Debt/Equity < 1
-1948.50
Current Ratio > 1
0.34

Profitability Score

Weak

PSXP struggles to sustain strong margins.

ROE > 15%
-51800.00%
Net Margin ≥ 15%
67.80%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is PSXP Expensive or Cheap?

P/E Ratio

PSXP trades at 12.45 times earnings. This suggests potential undervaluation.

12.45

PEG Ratio

When adjusting for growth, PSXP's PEG of -2.16 indicates potential undervaluation.

-2.16

Price to Book

The market values Phillips 66 Partners LP at -4836.45 times its book value. This may indicate undervaluation.

-4836.45

EV/EBITDA

Enterprise value stands at -3.65 times EBITDA. This is generally considered low.

-3.65

How Well Does PSXP Make Money?

Net Profit Margin

For every $100 in sales, Phillips 66 Partners LP keeps $67.80 as profit after all expenses.

67.80%

Operating Margin

Core operations generate 75.65 in profit for every $100 in revenue, before interest and taxes.

75.65%

ROE

Management delivers $-518.00 in profit for every $100 of shareholder equity.

-518.00%

ROA

Phillips 66 Partners LP generates $10.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

10.94%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $3.66 in free cash annually.

$3.66

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

12.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.16

vs 25 benchmark

P/B Ratio

Price to book value ratio

-4836.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1948.50

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.34

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-518.00

vs 25 benchmark

ROA

Return on assets percentage

0.11

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How PSXP Stacks Against Its Sector Peers

MetricPSXP ValueSector AveragePerformance
P/E Ratio12.4522.11 Better (Cheaper)
ROE-51800.00%950.00% Weak
Net Margin67.80%-62400.00% (disorted) Strong
Debt/Equity-1948.50-0.46 (disorted) Distorted
Current Ratio0.345.09 Weak Liquidity
ROA10.94%-11018380.00% (disorted) Strong

PSXP outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Phillips 66 Partners LP's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Commodity

EPS CAGR

N/A

Industry Style: Cyclical, Value, Commodity

FCF CAGR

N/A

Industry Style: Cyclical, Value, Commodity

Fundamental Analysis FAQ